Draxxin

دراكسين

Pharmaceutical

Draxxin (tulathromycin) Injectable Solution is a semi-synthetic macrolide antimicrobial containing 100 mg/mL of tulathromycin. Indicated for the treatment of bovine respiratory disease (BRD), infectious bovine keratoconjunctivitis (IBK/pinkeye), and bovine foot rot, as well as treatment and control of swine respiratory disease (SRD).

Dosage Form

N/A

Product Type

Pharmaceutical

Manufacturer

Zoetis

Package

50 mL, 100 mL, 250 mL, and 500 mL vials

Dosages

Species	Dosage	Route	Duration
Cattle	2.5 mg/kg (1.1 mL/100 lb body weight)	Subcutaneous (SC)	Single injection
Swine	2.5 mg/kg (0.25 mL/22 lb body weight)	Intramuscular (IM)	Single injection

Withdrawal Periods

Species	Meat (days)	Milk (days)	Eggs (days)
Cattle	18
Swine	5

Indications

Treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma bovis.
Control of respiratory disease in cattle at high risk of developing BRD.
Treatment of infectious bovine keratoconjunctivitis (IBK) associated with Moraxella bovis.
Treatment of bovine foot rot (interdigital necrobacillosis) associated with Fusobacterium necrophorum and Porphyromonas levii.
Treatment of swine respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Bordetella bronchiseptica, and Haemophilus parasuis.

Contraindications

Do not use in animals with known hypersensitivity to macrolide antibiotics.

Precautions

Subcutaneous administration in cattle can cause transient tissue reaction at injection site.
Effects of tulathromycin on bovine or swine reproductive performance, pregnancy, and lactation have not been determined.

Side Effects

Transient local pain or swelling at the injection site.

Images

Documents

Draxxin Prescribing Information
Leaflet

Download

Active Ingredients

Tulathromycin
100 mg/mL

Diseases

Companies

Zoetis
Manufacturer

Alternatives

No alternatives available.